OTCMKTS:SFOSF Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis $1.88 0.00 (0.00%) As of 11/17/2026 09:30 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Shanghai Fosun Pharmaceutical (Group) Stock (OTCMKTS:SFOSF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SFOSF alerts:Sign Up Key Stats Today's Range$1.88▼$1.8850-Day Range$1.88▼$2.4552-Week Range$1.88▼$2.86Volume3,000 shsAverage Volume1,308 shsMarket CapitalizationN/AP/E Ratio1.60Dividend Yield14.40%Price TargetN/AConsensus RatingN/A Company Overview Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based healthcare company founded in 1994 and headquartered in Shanghai. Its business spans pharmaceutical research and development, manufacturing and sales, as well as medical devices, diagnostics and healthcare services. The company develops and markets medicines in areas that include oncology, cardiovascular and metabolic diseases, and infectious diseases. Its portfolio also includes biological medicines and other pharmaceutical products, alongside diagnostic products and medical equipment. Fosun Pharma serves customers in China and international markets through its own operations and partnerships. It has expanded beyond pharmaceuticals into healthcare services, including hospital-related businesses, as part of its broader healthcare platform.AI Generated. May Contain Errors. Read More Receive SFOSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Fosun Pharmaceutical (Group) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SFOSF Stock News HeadlinesFosun Pharma Sets October Board Meeting to Approve Q3 ResultsOctober 12, 2026 | tipranks.comShanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Q2 2026 Earnings Call TranscriptSeptember 28, 2026 | seekingalpha.comBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all. | Banyan Hill Publishing (Ad)Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 BillionSeptember 6, 2026 | prnewswire.comShanghai Fosun Pharma Executes HK$3.6 Million H-Share BuybackAugust 27, 2026 | tipranks.comFosun Pharma Sets August Board Meeting to Approve 2026 Interim ResultsAugust 13, 2026 | tipranks.comFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination DrugAugust 3, 2026 | tipranks.comFosun Pharma Sets Final 2025 Dividend and Withholding Tax Terms for H-Share InvestorsJune 16, 2026 | tipranks.comSee More Headlines SFOSF Stock Analysis - Frequently Asked Questions How have SFOSF shares performed this year? Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $2.50 at the beginning of the year. Since then, SFOSF stock has decreased by 25.0% and is now trading at $1.8750. How do I buy shares of Shanghai Fosun Pharmaceutical (Group)? Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SFOSF CIKN/A Webwww.fosunpharma.com Phone86-21-3398-7000FaxN/AEmployees40,603Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio1.60 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:SFOSF) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Fosun Pharmaceutical (Group) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.